Mike Fagan,
Editor
March 21, 2025
Finally, with the safe return and hero’s… or shall we say dolphin’s welcome of NASA astronauts Barry “Butch” Wilmore and Sunita “Suni” Williams following an unexpectedly long residency in space, the area of space medicine has been thrust back into the public and investment spotlight.
After nearly nine months in space sans gravity — not to mention Suni’s new women’s record for total spacewalking at 62 hours, 6 minutes — the focus now shifts to the numerous health challenges, both physiological and psychological, that can arise from spending a prolonged period in space.
It’s a nascent area of science and medicine that’s gaining increased attention, importance, and investor interest as NASA and international partners work toward establishing a long-term presence on the Moon via the Artemis program.
The program is expected to further serve as a stepping stone to future human missions to Mars, the eventual establishment of lunar bases, and the development of new technologies related to deep-space travel.
Hence, as we set our sights on setting up shop beyond Earth’s atmosphere, a key area of space medicine that’s rapidly emerging is the study of the effects on the human body of logging extended time in the floatiness of microgravity.
One of the most pressing concerns is the rapid decrease in muscle mass and the acceleration of bone loss that can occur under such conditions.
Without Earth’s gravity pulling us downwards, bones that support the body’s weight can lose 1% to 1.5% of mineral density on average per month in space, which can be further exacerbated by a lack of proper diet and exercise.
The change in gravity can also lead to blood and cerebrospinal fluid shifting upward from the lower extremities to the head and eyes, which can result in eye and brain structural changes.
Dr. Shenhav Shemer, professor of Biology at the Technion Israel Institute of Technology, says, “A mission of this length definitely poses a much greater risk of long-term muscle atrophy and strength loss, which are often impossible to fully reverse.”
Another primary concern is space radiation, which differs from radiation experienced on Earth. In essence, the level of radiation exposure rises as we move beyond the protective confines of the Earth’s magnetosphere.
Such exposure can lead to radiation sickness and a higher lifetime risk of cancer, degenerative disease, and central nervous system ailments.
Next, of course, are the potentially negative psychological effects that can arise from being isolated in a closed environment for an extended period of time (something we’re also currently hearing news stories about from a remote base in Antarctica).
To address these and other critical health challenges posed by space travel, the science of space medicine is tasked with studying the effects of space travel on the human body and developing technologies, treatments, and preventative measures to mitigate the effects.
Importantly, from an investor standpoint, the benefits of space medicine extend far beyond space exploration itself as many of the technologies and medical advancements being developed for space missions will no doubt have direct applications here on Earth.
For example, the study of how the human body adapts to extreme conditions in space offers valuable insights into human biology, aging, and the potential for long-term health optimization.
Space medicine is also closely linked to advancements in the development of potentially life-saving drugs that can only be made in microgravity in specially designed space capsules, making it a key driver of broader healthcare innovations.
For investors, the current early state of space medicine presents an exciting opportunity.
Much like AI just a few short years ago — space medicine is poised for exponential growth as government space agencies such as NASA, as well as private and publicly traded companies push forward with ambitious space exploration initiatives.
Those ambitions are now opening the door for contrarian investors to capitalize on the enormous projected growth curve ahead.
We here at Daily Profit Cycle are absolutely loving the fact that the market for space medicine is still in its infancy.
It means that, as space travel increases and as colonization ambitions rise, the demand for medical solutions in this niche market will grow by leaps and bounds.
It also means that staking a strategic claim in this nascent field today could yield significant portfolio returns for years to come as we move closer to regular human space travel and as the commercialization of space exploration continues to evolve.
Moreover, with space medicine being so interdisciplinary — combining fields like biomedicine, aerospace engineering, and data analytics — the companies and research institutions involved are likely to enter into multibillion-dollar collaborations that could mean even bigger profit opportunities ahead. Think ‘Stargate’ in the AI sector.
Hence, for foresighted investors, space medicine represents a unique opportunity to tap into a little-known niche with the potential to be at the forefront of both space exploration and the next wave of medical breakthroughs.
Naturally, we all want to Live Long & Prosper!
And to that end, our own John Carl and Chris Curl over at Digital Dispatch are currently putting the final touches on an exclusive, in-depth feature presentation on the best ways to invest in space medicine.
The dolphins have spoken… this is something you definitely do not want to miss! The guys expect their presentation to be out in about a week. We’ll let you know the moment it launches!
Yours in profits,
Mike Fagan
Editor, Daily Profit Cycle